TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30033159

Group type: EXPERIMENTAL
Intervention: 1 mg/kg caffeine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0 mg/kg caffeine (placebo)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 3 mg/kg caffeine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Caffeine treatment overall
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Caffeine treatment and BMI
Number of subjects: 50
Study: 27236320

Group type: EXPERIMENTAL
Intervention: Voriconazole 50 mg oral
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voriconazole 400 mg oral
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voriconazole 50 mg intravenous
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voriconazole 400 mg intravenous
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voriconazole (both doses)
Number of subjects: 14
Study: 25007675

Group type: EXPERIMENTAL
Intervention: Local packing of Nasopore combined with hemocoagulase injection (1 U of hemocoagulase dissolved in 0.5 ml saline)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Local packing of Nasopore combined with saline injection (0.5 ml saline)
Number of subjects: 68
Study: 22581209

Group type: EXPERIMENTAL
Intervention: Stapled ileocolonic anastomosis
Number of subjects: 84

Group type: COMPARATOR
Intervention: Handsewn anastomosis
Number of subjects: 84
Study: 20926013

Group type: EXPERIMENTAL
Intervention: multimodal analgesia protocol (oral celecoxib and tramadol before and after surgery; intra‐articular injection of morphine, ropivacaine, adrenaline, and betamethasone during surgery)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: multimodal analgesia protocol
Number of subjects: 100

Group type: COMPARATOR
Intervention: oral and intra‐articular placebo
Number of subjects: 100
Study: 18705758

Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 11050
Study: 15653024

Group type: EXPERIMENTAL
Intervention: Metoprolol controlled release/extended release (CR/XL)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 12435158

Group type: EXPERIMENTAL
Intervention: Chloroquine and 5-day regimen of primaquine at 15 mg/day
Number of subjects: 1482

Group type: COMPARATOR
Intervention: Chloroquine alone
Number of subjects: 1482
Study: 11910651

Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2.0 mg/dienogest 2.0 mg (Climodien)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2.0 mg/dienogest 3.0 mg (E2Val 2/DNG 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estradiol 2.0 mg/estriol 1.0 mg/norethisterone acetate 1.0 mg (Kliogest)
Number of subjects: 0
Study: 9239164

Group type: EXPERIMENTAL
Intervention: Tegafur
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: 5‐FU
Number of subjects: 488

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 488
Study: 8478230

Group type: EXPERIMENTAL
Intervention: Strontium-89 (10.8 mCi single injection)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 3762845

Group type: EXPERIMENTAL
Intervention: Paregoric
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Phenobarbital (combined loading and titration)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: More than one agent (including diazepam)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 85
Study: 30471827

Group type: EXPERIMENTAL
Intervention: The Bedside PEWS
Number of subjects: 16213

Group type: COMPARATOR
Intervention: CDR PEWS
Number of subjects: 16213
Study: 30132009

Group type: EXPERIMENTAL
Intervention: Progressive resistance training with elastic bands
Number of subjects: 59

Group type: COMPARATOR
Intervention: General physical exercise
Number of subjects: 59
Study: 28189551

Group type: EXPERIMENTAL
Intervention: Minor background vibratory stimulation to the trunk using a vibrating cushion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recorded sound vibrations
Number of subjects: 0

Group type: COMPARATOR
Intervention: No extra sensory stimulation (Control group)
Number of subjects: 0
Study: 26206832

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole Blood (WB)
Number of subjects: 0
Study: 23350933

Group type: EXPERIMENTAL
Intervention: Pay-for-performance program (P4P) providing A$40 and A$100 for diabetes and asthma treatment, and A$35 for cervical cancer screening.
Number of subjects: 0
Study: 21146687

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 31

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 31
Study: 18773727

Group type: EXPERIMENTAL
Intervention: Training with mismatched locomotor and visual input
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walking to visual targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Locating visual targets in a spatial updating task
Number of subjects: 0
Study: 17395029

Group type: EXPERIMENTAL
Intervention: Insulin-Glucose Infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study: 12701852

Group type: EXPERIMENTAL
Intervention: Patients with cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palliative care patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (general practice attendees)
Number of subjects: 0
Study: 11149435

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 15 ml/kg ideal body weight on ZEEP
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on ZEEP
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on positive end‐expiratory pressure of 10 cm H2O
Number of subjects: 39
Study: 8941007

Group type: EXPERIMENTAL
Intervention: Modified type IV‐V radical hysterectomy with systematic pelvic and aortic lymphadenectomy
Number of subjects: 42
Study: 1493837

Group type: EXPERIMENTAL
Intervention: Penicillin (Phenoxymethylpenicillin) 250 mg t.i.d. for adults and 125 mg t.i.d. for children
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 173
Study: 30537874

Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy as an adjunct to intensive family preservation services (n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study: 28027283

Group type: EXPERIMENTAL
Intervention: PCV‐13 booster
Number of subjects: 178

Group type: COMPARATOR
Intervention: PCV‐10 booster
Number of subjects: 178
Study: 25636550

Group type: EXPERIMENTAL
Intervention: Closed surgical exposure technique
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Open surgical exposure technique
Number of subjects: 67
Study: 23034539

Group type: EXPERIMENTAL
Intervention: Active CPAP
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham-CPAP
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 21905254

Group type: EXPERIMENTAL
Intervention: Pain group (n = 13) - resistance training during pain induced by injections of painful hypertonic saline
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (n = 14) - resistance training during a nonpainful condition with injection of isotonic saline
Number of subjects: 27
Study: 20074791

Group type: EXPERIMENTAL
Intervention: Raltegravir (400 mg twice daily; n=353)
Number of subjects: 707

Group type: COMPARATOR
Intervention: Lopinavir-ritonavir (two 200 mg/50 mg tablets twice daily; n=354)
Number of subjects: 707
Study: 17976337

Group type: EXPERIMENTAL
Intervention: Double-dose vitamin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D nutritional status improvement
Number of subjects: 0
Study: 15784802

Group type: EXPERIMENTAL
Intervention: Single pre-exposure (group 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Three pre-exposures (group 3)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No pre-exposure (group 0)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cortisol levels
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: TNF-alpha levels
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Postrotational nausea
Number of subjects: 24
Study: 12468774

Group type: EXPERIMENTAL
Intervention: Audiological testings
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Electronystagmography
Number of subjects: 12
Study: 10496155

Group type: EXPERIMENTAL
Intervention: TETRAMUNE (combination vaccine of HibTITER and DTP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: DTP and HibTITER administered concurrently (separate group)
Number of subjects: 93
Study: 7570885

Group type: EXPERIMENTAL
Intervention: Intrarectal Quinimax® (20 mg/kg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intramuscular Quinimax® (12.5 mg/kg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intrarectal Quinimax®
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intramuscular Quinimax®
Number of subjects: 66
Study: 2668757

Group type: EXPERIMENTAL
Intervention: Single-dose ketoconazole (400 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Single-dose ketoconazole (800 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo vaginal suppositories
Number of subjects: 90
Study: 779006

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (320 mg trimethoprim and 1600 mg sulphamethoxazole daily for 10 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nitrofurantoin (200 mg/day for 10 days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nitrofurantoin
Number of subjects: 45
Study: 31985266

Group type: EXPERIMENTAL
Intervention: ALTENS four‐times weekly for 6 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: ALTENS two‐times weekly for 12 weeks
Number of subjects: 30
Study: 30888217

Group type: EXPERIMENTAL
Intervention: Pycnogenol (PYC) 50 mg per day for 4 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Escitalopram (ESC) only
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pycnogenol (PYC)
Number of subjects: 72
Study: 27322187

Group type: EXPERIMENTAL
Intervention: Early closure of temporary ileostomy (8-13 days after stoma creation)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Late closure of temporary ileostomy (>12 weeks after index surgery)
Number of subjects: 127
Study: 26883526

Group type: EXPERIMENTAL
Intervention: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge
Number of subjects: 851

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 851
Study: 24248551

Group type: EXPERIMENTAL
Intervention: Serial plaster casting
Number of subjects: 27

Group type: COMPARATOR
Intervention: Bebax orthoses
Number of subjects: 27
Study: 23085147

Group type: EXPERIMENTAL
Intervention: α(+)-thalassemia homozygote (‐α/‐α)
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: α(+)-thalassemia heterozygote (αα/‐α)
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Wild-type children
Number of subjects: 1112
Study: 19912710

Group type: EXPERIMENTAL
Intervention: Intraoperative pedobarography (IP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intraoperative pedobarography (no IP)
Number of subjects: 100
Study: 17405834

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with infliximab (group 4)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Step‐up combination therapy (group 2)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Sequential monotherapy (group 1)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with tapered high‐dose prednisone (group 3)
Number of subjects: 508

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 508
Study: 15588120

Group type: EXPERIMENTAL
Intervention: Activated protein C
Number of subjects: 0
Study: 11271694

Group type: EXPERIMENTAL
Intervention: Behavioral self‐management (BSM)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Waiting list control (WLC)
Number of subjects: 82
Study: 9611312

Group type: EXPERIMENTAL
Intervention: end-to-end anastomosis
Number of subjects: 239

Group type: COMPARATOR
Intervention: end-to-side anastomosis
Number of subjects: 239

Group type: COMPARATOR
Intervention: side-to-side anastomosis
Number of subjects: 239
Study: 7848933

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3% chloroprocaine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Unblocked dermatome (control)
Number of subjects: 9
Study: 3200596

Group type: EXPERIMENTAL
Intervention: Pump PA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pump PB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study: 31664960

Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program at week 2 of BMQ
Number of subjects: 2831

Group type: COMPARATOR
Intervention: Delayed Intervention Control (R2MR at week 9 of BMQ)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program under high fidelity conditions
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program under poor fidelity conditions
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program
Number of subjects: 2831
Study: 28630194

Group type: EXPERIMENTAL
Intervention: 1 g intravenous fosfomycin disodium
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 8 g intravenous fosfomycin disodium
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 3 g oral fosfomycin tromethamine
Number of subjects: 28
Study: 26525296

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation programme conducted once a week for four months by trained community workers supervised by a qualified physiotherapist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard clinic management offered to the control group.
Number of subjects: 0
Study: 23489710

Group type: EXPERIMENTAL
Intervention: Insulin therapy administered by insulin pen
Number of subjects: 450

Group type: COMPARATOR
Intervention: Lower IDS satisfaction
Number of subjects: 450

Group type: COMPARATOR
Intervention: Lower IDS social acceptability
Number of subjects: 450

Group type: COMPARATOR
Intervention: More positive expectations of insulin therapy
Number of subjects: 450
Study: 20881402

Group type: EXPERIMENTAL
Intervention: Alcohol + Water (0.5 liter)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo + Water (0.5 liter)
Number of subjects: 74
Study: 19180896

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcipotriene 0.005% betamethasone dipropionate 0.064% ointment
Number of subjects: 0
Study: 18322602

Group type: EXPERIMENTAL
Intervention: Fufang Biejia Ruangan tablet (FBRt)
Number of subjects: 420

Group type: COMPARATOR
Intervention: He Luo Shu Gan capsule (Control)
Number of subjects: 420
Study: 15670971

Group type: EXPERIMENTAL
Intervention: Direct venography technique
Number of subjects: 83

Group type: COMPARATOR
Intervention: Occlusive venography technique
Number of subjects: 83
Study: 12136475

Group type: EXPERIMENTAL
Intervention: Immunodepressive therapy
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Intravenous pulse therapy with cyclophosphamide
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Oral cyclophosphamide
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Intravenous pulse therapy
Number of subjects: 2000

Group type: COMPARATOR
Intervention: IgA nephropathy (IgA-N)
Number of subjects: 2000
Study: 10417589

Group type: EXPERIMENTAL
Intervention: Aquaphor mixed with vitamin E (B)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Aquaphor (A)
Number of subjects: 15
Study: 7573298

Group type: EXPERIMENTAL
Intervention: 0.1 mg/day estradiol patch
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: 0.05 mg/day estradiol patch
Number of subjects: 603

Group type: COMPARATOR
Intervention: Climara patch
Number of subjects: 603

Group type: COMPARATOR
Intervention: Conjugated equine estrogens (Premarin)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study: 2201730

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7337837

Group type: EXPERIMENTAL
Intervention: Mantle irradiation or inverted Y radiotherapy (group 7701 S)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Focal irradiation only (group 7701 F)
Number of subjects: 79
Study: 31464757

Group type: EXPERIMENTAL
Intervention: Gaming balance board intervention for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group using computer mouse in standing position
Number of subjects: 56
Study: 30991441

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2331
Study: 27977819

Group type: EXPERIMENTAL
Intervention: Feather-edge preparation
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Deep chamfer preparation
Number of subjects: 58
Study: 25853745

Group type: EXPERIMENTAL
Intervention: Fresh red cells (stored for less than 8 days)
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Standard-issue red cells (the oldest compatible units available)
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Fresh red cells
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Standard-issue red cells
Number of subjects: 1211
Study: 23548118

Group type: EXPERIMENTAL
Intervention: Paeoniflorin (PAE) + cervus and cucumis polypeptide injection (CCPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX) + leflunomide (LEF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) + leflunomide (LEF) + CCPI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CCPI (as an add-on to DMARDs)
Number of subjects: 0
Study: 22462231

Group type: EXPERIMENTAL
Intervention: Blood-increasing decoction and blood-generating powder for 1-3 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Amino-polypeptide as a basic treatment
Number of subjects: 200
Study: 19624787

Group type: EXPERIMENTAL
Intervention: Tolterodine ER (4 mg)
Number of subjects: 4163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4163
Study: 16625009

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 15272149

Group type: EXPERIMENTAL
Intervention: Post-occlusive reactive hyperemia (PORH) test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVD indicators
Number of subjects: 0
Study: 11701786

Group type: EXPERIMENTAL
Intervention: Randomized trials involving fracture care
Number of subjects: 19942
Study: 9046249

Group type: EXPERIMENTAL
Intervention: Vancomycin 20 micrograms/mL and Gentamicin 8 micrograms/mL in the irrigating fluid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (only irrigating fluid)
Number of subjects: 120
Study: 7959572

Group type: EXPERIMENTAL
Intervention: OK-432 (administered pre-operatively via hepatic artery)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no treatment with OK-432)
Number of subjects: 10
Study: 3146369

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 30117638

Group type: EXPERIMENTAL
Intervention: Fresh activated Miswak
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inactivated Miswak
Number of subjects: 24
Study: 26247014

Group type: EXPERIMENTAL
Intervention: COH‐IUI
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 238
Study: 23595590

Group type: EXPERIMENTAL
Intervention: Topical zinc oxide treatment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Parenteral zinc, copper, and selenium combined
Number of subjects: 42

Group type: COMPARATOR
Intervention: Elective surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patients with abscesses
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wound edges
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wound edge
Number of subjects: 42
Study: 21709199

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study: 19535421

Group type: EXPERIMENTAL
Intervention: Stearate-enriched plant sterol esters (3 g/d, 1 g three times per day with meals)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Stearate-enriched plant sterol esters
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 17166443

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention including semi-recumbent position, mosapride citrate, and endotracheal tube for continuous subglottic secretions drainage
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard endotracheal tube (control group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention
Number of subjects: 86
Study: 15317602

Group type: EXPERIMENTAL
Intervention: Nateglinide (90 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11514302

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study: 9431633

Group type: EXPERIMENTAL
Intervention: Specific exercise treatment program involving training of deep abdominal muscles and co-activation of lumbar multifidus for 10 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control treatment as directed by treating practitioner
Number of subjects: 44
Study: 8487344

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 592

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 592

Group type: COMPARATOR
Intervention: Cefoxitin (specifically for patients with colon injuries)
Number of subjects: 592
Study: 3388875

Group type: EXPERIMENTAL
Intervention: sucralfate (4 g/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ranitidinhydrochloride (336 mg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ranitidinhydrochloride and pirenzepindihydrochloride (100 mg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 120